P704: ASCIMINIB PROVIDES DURABLE MOLECULAR RESPONSES IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) WITH THE T315I MUTATION: UPDATED EFFICACY AND SAFETY DATA FROM A PHASE I TRIAL

Autor: T. Hughes, J. E. Cortes, D. Réa, M. J. Mauro, A. Hochhaus, D.-W. Kim, K. Sasaki, F. Lang, M. C. Heinrich, M. Breccia, M. Deininger, Y.-T. Goh, J. J. Janssen, M. Talpaz, V. Gómez García de Soria, P. le Coutre, S. Kapoor, S. Cacciatore, F. Polydoros, N. Agrawal, F.-X. Mahon

Publikováno v: HemaSphere, Vol 6, Pp 599-600 (2022)

Externí odkaz: https://doaj.org/article/07750eb3f1c149bfb8cc8180c74353ed

Results of allogeneic stem cell transplantation in the Spanish MDS registry: Prognostic factors for low risk patients

Autor: V. Gómez-García de Soria, Rodrigo Martino, Alicia Bailen, Mar Tormo, Andrés Insunza, F. Iniesta, M.C. del Cañizo, Blanca Xicoy, I. Cordoba, María-Luz Amigo, Rafael F. Duarte, Luis Benlloch, Teresa Bernal, Mercedes Sánchez-Barba, Guillermo Sanz, M. Díez Campelo, Olga López-Villar

Publikováno v: LEUKEMIA RESEARCH
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Although new agents have been approved for the treatment of MDS, the only curative approach is allogeneic hematopoietic stem cell transplantation (HSCT) and thus, in particular circumstances this procedure has been proposed as a treatment option for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ceb78f4ff887be03f8c283e446fdcd94
https://doi.org/10.1016/j.leukres.2014.07.009

A high migratory capacity of donor T-cells in response to the lymph node homing receptor CCR7 increases the incidence and severity of GvHD

Autor: Beatriz Colom-Fernández, V López-Huete, Cecilia Muñoz-Calleja, Ana Marcos-Jiménez, Itxaso Portero-Sainz, Carlos Cuesta-Mateos, C Fernández-Arandojo, Beatriz Somovilla-Crespo, Anna Kreutzman, A de Rosendo-Serrano, V Gómez-García de Soria, Mercedes Royg, A Ramírez-Mengíbar, Lorena Vega-Piris

Publikováno v: Bone marrow transplantation. 52(5)

The pathogenesis of GvHD involves migration of donor T-cells into the secondary lymphoid organs in the recipient, which is steered by two homing molecules, CD62L and CCR7. Therefore, we investigated whether the migratory capacity of donor T-cells is

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b415a1fa3d0da60fdd6460cb0b1e75d
https://pubmed.ncbi.nlm.nih.gov/28112745

[Treatment of leukemia relapsed after allogenic bone marrow transplantation with donor lymphocyte infusion: report of 11 cases]

Autor: C, Sanz Rodríguez, J L, Steegmann, A, Granda, R, de la Cámara, A, Figuera, R, Arranz, V, Gómez-García de Soria, A, Alegre, J M, Fernández-Rañada

Publikováno v: Sangre. 44(6)

Donor leukocyte infusions (DLI) are useful for treating leukaemic relapse after allogeneic bone marrow transplantation (BMT). We reviewed our experience with eleven patients who received DLI between 1995 and 1997.The diagnoses prior to DLI were: chro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e39d3f0b8b3e14384ccec7951dd1e5ae
https://pubmed.ncbi.nlm.nih.gov/10822760

Hepatitis C and G virus infection and liver dysfunction after allogeneic bone marrow transplantation: results from a prospective study

Autor: E, Rodriguez-Iñigo, J F, Tomás, V, Gómez-García de Soria, J, Bartolomé, I, Pinilla, M J, Amaro, V, Carreño, J M, Fernández-Rañada

Publikováno v: Blood. 90(3)

Acute and chronic liver dysfunction is common after allogeneic bone marrow transplantation (BMT). Although toxicity, graft versus-host disease (GVHD), and viral infections are the major causes, etiologic diagnosis is difficult and often remains unkno

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a708b43133fd598f07d4b5ca6c2519df
https://pubmed.ncbi.nlm.nih.gov/9242569